H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Neuroscience H-index 162 Citations 108,733 1,370 World Ranking 26 National Ranking 3
Medicine H-index 187 Citations 149,940 1,964 World Ranking 98 National Ranking 2

Research.com Recognitions

Awards & Achievements

2017 - Nordic Medical Prize, SalusAnsvar/Ulf Nilsonnes Foundation for Medical Research

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Alzheimer's disease

His primary scientific interests are in Alzheimer's disease, Internal medicine, Pathology, Cerebrospinal fluid and Dementia. His study focuses on the intersection of Alzheimer's disease and fields such as Central nervous system disease with connections in the field of Cognitive disorder. In his research, Cohort study is intimately related to Oncology, which falls under the overarching field of Internal medicine.

His Cerebrospinal fluid research includes elements of Csf biomarkers, Immunology, Disease, Amyloid and Traumatic brain injury. His research in Dementia intersects with topics in Cognition, Neurology and Neuroimaging. The study incorporates disciplines such as Immunoassay, Neuropathology and Neurodegeneration in addition to Biomarker.

His most cited work include:

  • Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. (3383 citations)
  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)

What are the main themes of his work throughout his whole career to date?

Kaj Blennow mainly investigates Internal medicine, Cerebrospinal fluid, Disease, Pathology and Biomarker. His work deals with themes such as Endocrinology, Neurology and Oncology, which intersect with Internal medicine. Kaj Blennow has included themes like Gastroenterology, Neurodegeneration, Immunology and Amyloid in his Cerebrospinal fluid study.

The various areas that Kaj Blennow examines in his Disease study include Neuroimaging, Neuroscience and Clinical trial, Bioinformatics. His Dementia research is multidisciplinary, incorporating elements of Cognition and Cohort. The concepts of his Alzheimer's disease study are interwoven with issues in Apolipoprotein E and Central nervous system disease, Degenerative disease.

He most often published in these fields:

  • Internal medicine (61.40%)
  • Cerebrospinal fluid (58.14%)
  • Disease (42.31%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (61.40%)
  • Cerebrospinal fluid (58.14%)
  • Disease (42.31%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Cerebrospinal fluid, Disease, Biomarker and Dementia. He works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Neuroimaging. His Cerebrospinal fluid study is concerned with the larger field of Pathology.

His biological study spans a wide range of topics, including Clinical trial, Bioinformatics and Cognition, Neuroscience. His Biomarker research is multidisciplinary, relying on both Positron emission tomography, Prospective cohort study, Area under the curve and Glial fibrillary acidic protein. His Dementia study integrates concerns from other disciplines, such as Alzheimer's disease, Apolipoprotein E and Cohort.

Between 2019 and 2021, his most popular works were:

  • Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
  • Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. (123 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)

4372 Citations

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)

2575 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos.
Lancet Neurology (2006)

1867 Citations

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Leslie M. Shaw;Hugo Vanderstichele;Malgorzata Knapik-Czajka;Christopher M. Clark.
Annals of Neurology (2009)

1829 Citations

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Kaj Blennow;Harald Hampel;Michael Weiner;Henrik Zetterberg.
Nature Reviews Neurology (2010)

1717 Citations

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow.
The New England Journal of Medicine (2014)

1545 Citations

CSF markers for incipient Alzheimer's disease

Kaj Blennow;Harald Hampel.
Lancet Neurology (2003)

1440 Citations

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)

1247 Citations

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura.
Nature Medicine (2007)

1149 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Kaj Blennow

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 365

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 336

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 244

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 231

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 229

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 211

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 210

Charlotte E. Teunissen

Charlotte E. Teunissen

Vrije Universiteit Amsterdam

Publications: 207

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 206

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 196

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 192

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 182

Michael W. Weiner

Michael W. Weiner

University of California, San Francisco

Publications: 175

Leslie M. Shaw

Leslie M. Shaw

University of Pennsylvania

Publications: 169

Dag Aarsland

Dag Aarsland

King's College London

Publications: 165

Something went wrong. Please try again later.